Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF – Get Free Report) was down 0.7% during trading on Wednesday . The company traded as low as $14.40 and last traded at $14.40. Approximately 1,294 shares were traded during mid-day trading, a decline of 89% from the average session volume of 12,097 shares. The stock had previously closed at $14.50.
Analyst Ratings Changes
Separately, Jefferies Financial Group lowered shares of Kyowa Kirin to a “hold” rating in a research report on Tuesday, September 8th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Reduce”.
View Our Latest Stock Analysis on KYKOF
Kyowa Kirin Price Performance
About Kyowa Kirin
Kyowa Kirin Co, Ltd. is a global biopharmaceutical company headquartered in Tokyo, Japan, specializing in the research, development and commercialization of innovative therapies. Established through the merger of Kyowa Hakko Kogyo Co, Ltd. and Kirin Pharma Co, Ltd. in 2008, the company operates as part of the Kirin Group and pursues a mission of delivering cutting-edge medicines in areas of high unmet medical need. Its corporate structure supports integrated research and development, manufacturing and worldwide licensing activities.
The company’s therapeutic focus spans oncology, nephrology, immunology and central nervous system disorders.
Recommended Stories
- Five stocks we like better than Kyowa Kirin
- Chips to Bots: Qualcomm’s Agentic AI Breakout
- Ciena Fell 40%—Now One Analyst Sees 50% Upside
- Energy Transfer Taps the AI Power Boom
- Viking’s Obesity Edge May Be Staying Power, Not Weight Loss
Receive News & Ratings for Kyowa Kirin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kyowa Kirin and related companies with MarketBeat.com's FREE daily email newsletter.
